Rice University identified 15 more pandemic-related research projects to receive support from a new research fund. Getty Images

Researchers at a Houston institution have been rewarded for their work that focuses on COVID-19 and how it's affected various aspects of life.

Rice University has named its two more rounds of recipients of its COVID-19 Research Fund — an initiative created to support projects that are innovating solutions and services amid the COVID-19 crisis. In April, the COVID-19 Research Fund Oversight and Review Committee — led by engineering professor and special adviser to the provost, Marcia O'Malley — selected four projects led by Rice faculty members across industries from biomedicine to humanities that will receive the first round of funds.

The committee named another round of recipients in May and the third and final round this month. Here are the projects from the last two rounds of grants:

  • Rapid point-of-care device to detect severe cases of COVID-19 by Kevin McHugh and Peter Lillehoj of Rice and Cassian Yee of the University of Texas MD Anderson Cancer Center.
  • A mobile phone-based blood serum test for COVID-19 antibodies by Lillehoj, Wen Hsiang Chen of Baylor College of Medicine and James Le Duc of Galveston National Laboratory. The mobile test would be faster and more precise.
  • A handbook addressing pandemic response initiatives for health officials by Kirsten Ostherr and Lan Li of Rice; Thomas Cole of the McGovern Medical School at the University of Texas Health Science Center, Houston; Robert Peckham of Hong Kong University; and Sanjoy Bhattacharya of York University.
  • A look at COVID-19's effect on vehicle travel and electric power generation and air quality by Daniel Cohan and Daniel Kowal of Rice. Using both on-the-ground and satellite data, the researchers will look at various air pollutants.
  • A study on Harris County residents' compliance to stay-at-home orders by Flavio Cunha, Patricia DeLucia, Fred Oswald, Ekim Cem Muyan and E. Susan Amirian of Rice. The researchers will survey residents — particularly low-socioeconomic populations.
  • A look at how pollution and economics affect each other turing a pandemic-caused crisis by Sylvia Dee, Ted Loch-Temzelides, Caroline Masiello and Mark Torres of Rice. Thanks to stay-at-home initiatives, the study can look at which economic sectors contribute the most to carbon emissions.
  • A study on long-term effects of COVID-19 on human development by Fred Oswald of Rice, Rodica Damian and Tingshu Liu of the University of Houston and Patrick Hill of Washington University. The project looks at the pandemic's affect on social contexts including occupational, educational, community, family, lifestyle, health and financial.
  • A predictive model of Houston's COVID-19 condition by Daniel Kowal, assistant professor of statistics, and Thomas Sun, a graduate student, at Rice. The project will compare Houston to locations that are similar and further along the disease incidence curve.
  • A survey of how stay-at-home orders affected low-income families by Amelyn Ng, Wortham Fellow at Rice Architecture, and Gabriel Vergara of One Architecture and Urbanism. he survey will focus on Houston's Greater Fifth Ward.
  • Research on antibodies for disease prevention by Laura Segatori, associate professor of bioengineering and of chemical and bimolecular engineering and biosciences, and Omid Veiseh, assistant professor of bioengineering, at Rice. The two scientists plan to engineer cell lines for the rapid development of clinically translatable neutralizing antibodies for infection control.
  • An analysis of working conditions amid the pandemic by Danielle King, assistant professor of psychological sciences at Rice. King will look into both employees who can no longer go to the workplace, like teachers, and those required to, like nurses, to see what resources are most effective.
  • An oxygen sensing device by Michael Wong, department chair and a professor of chemical and biomolecular engineering, and Rafael Verduzco, associate professor of chemical and biomolecular engineering, of Rice and John Graf of NASA. The team will continue working on a NASA-designed prototype ventilator for rapid deployment based on an off-the-shelf automotive oxygen sensor.
  • A study on social distancing for musicians by Ashok Veeraraghavan, Robert Yekovich and Ashutosh Sabharwal of Rice and John Mangum of the Houston Symphony. The project will look into airflow of wind instruments using high-speed imaging.
  • Looking into public health initiatives and their use in COVID-19 by Hulya Eraslan, Rossella Calvi, Dibya Deepta Mishra and Ritika Sethi of Rice. The team will look at election data with a goal is to understand the impact of political alignment across levels of government on the effectiveness of its response.
  • Research on optimizing nursing staff schedules by Andrew Schaefer, Illya Hicks and Joseph Huchette of Rice and Nicole Fontenot of Houston Methodist Hospital. Researchers will employ data and technology to improve forecasting demand for nursing staff.
Four COVID-19-focused research projects have been selected by Rice University to receive funding. Photo courtesy of Rice University

Houston university announces first recipients of coronavirus research funding

covid heroes

Rice University has named several Houston researchers as recipients of funding as a part of a new initiative to support projects that are innovating solutions and services amid the COVID-19 crisis.

The university's COVID-19 Research Fund Oversight and Review Committee — led by engineering professor and special adviser to the provost, Marcia O'Malley — selected a few projects led by Rice faculty members across industries from biomedicine to humanities that will receive the first round of funds. However, the application window is ongoing, according to a press release, and additional awards are to be expected.

Here were the first projects and researchers to be selected by the committee.

A low-cost diagnostic tool

Rice researchers Rebecca Richards-Kortum and Kathryn Kundrod of Rice University along with Kathleen Schmeler of the University of Texas MD Anderson Cancer Center have identified a way to create a COVID-19 diagnostic device that costs less than $5,000 and less than $2 per test. It would also take fewer than 30 minutes to diagnose.

The researchers are also working with USAID and industry partners on a plan to scale the test to five countries in Africa. In the future, the device would enable broader SARS-CoV-2 testing locally and in low- and middle-income countries.

Richards-Kortum is a professor of bioengineering and electrical and computer engineering and director of Rice 360˚. Kundrod is a graduate student in bioengineering. Schmeler is a professor in the department of gynecologic oncology and reproductive medicine at MD Anderson.

A protective rubber harness to be worn over a face mask 

Jacob Robinson and Caleb Kemere, associate professors at Rice, along with Sahil Kuldip of MD Anderson, have discovered a low-cost, easy-to-manufacture rubber harness to be worn over surgical or cloth masks in order seal the masks. The seal would better prevent small airborne particles from getting around the masks.

Robinson is in Rice's electrical and computer engineering and bioengineering departments, while Kemere specializes in electrical and computer engineering. Kuldip is an assistant professor of plastic surgery at MD Anderson.

Wastewater monitoring for coronavirus contamination 

Rice researchers Lauren Stadler, Katherine Ensor and Loren Hopkins are working with the Houston Health Department and Houston Water on a plan to collect wastewater samples from local treatment plants to monitor for the presence of COVID-19.

With most people asymptomatic or experience only mild symptoms of COVID-19, the researchers are looking into the virus's presence in wastewater in order to track community infection.

Stadler, an assistant professor of civil and environmental engineering, and Ensor, the Noah G. Harding Professor of Statistics, are working with Hopkins, who is a professor in practice of statistics and chief environmental science officer for the Houston Health Department.

The identification of safe and healthy voting procedures 

Five Rice researchers — Robert Stein, Philip Kortum, Claudia Ziegler Acemyan, Daniel Wallach and Elizabeth Vann — are looking into steps Harris County can take to ensure that in-person voting is safe and keeps participants healthy. Through surveys with citizens, the team will help election officials survey both voters and poll workers on their voting preferences and concerns.

The research team spans campus departments: Stein is the Lena Gohlman Fox Professor of Political Science, Kortum is an associate professor of psychological sciences, Acemyan is an adjunct assistant professor of psychological sciences, Wallach is a professor of computer science and of electrical and computer engineering, and Vann is the director of programs and partnerships at the Center for Civic Leadership

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”